Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Atul Parikh"'
Autor:
Yacine Mazouzi, Fadoua Sallem, Francesca Farina, Alexis Loiseau, Natayme Rocha Tartaglia, Morgane Fontaine, Atul Parikh, Michèle Salmain, Christian Neri, Souhir Boujday
Publikováno v:
ACS Sensors. 7:1657-1665
Extracellular vesicles (EVs) are secreted nanoparticles that are involved in intercellular communication and that modulate a wide range of biological processes in normal and disease conditions. However, EVs are highly heterogeneous in terms of origin
Autor:
Hong Wang, Rahul Atul Parikh, Smit Patel, Sudeep K Siddappa Malleshappa, Roy C. Smith, Smith Giri, Kathan Mehta
Publikováno v:
The American Journal of Cardiology. 124:960-965
Venous thromboembolism (VTE) is an important cause of morbidity and mortality in the United States (US). The increasing rates of VTE in the US resulted in the surgeon general issuing a call to action to reduce VTE in 2008. The objective of our study
Autor:
Rahul Atul Parikh, John A. Taylor, Qi Chen, Benjamin L. Woolbright, Ping Chen, Elizabeth Marie Wulff-Burchfield, Jeffrey Holzbeierlein, Roy A. Jensen, Jeanne A. Drisko
Publikováno v:
Journal of Clinical Oncology. 40:e16540-e16540
e16540 Background: Neo-adjuvant cisplatin-based chemotherapy (NAC) is considered standard of care for patients with locally advanced disease. However, ̃40% of patients are cisplatin ineligible (CI) due to renal insufficiency, hearing loss or poor pe
Autor:
Joaquina Celebre Baranda, Gary C. Doolittle, Rahul Atul Parikh, Anup Kasi, Elizabeth Marie Wulff-Burchfield, Benjamin Powers, Robert E. Pluenneke, Marc Steven Hoffmann, Abdulraheem Yacoub, Anwaar Saeed, Larry R. Corum, Tara L. Lin, Weijing Sun, Margaret M. Mooney, Jeffrey Moscow, James H. Doroshow, Brittany Waters, S. Percy Ivy, Steven Gore, Roy A. Jensen
Publikováno v:
Journal of Clinical Oncology. 40:6542-6542
6542 Background: Access to health care including clinical trials (CT) leading to paradigm-changing cancer treatments are critical for high quality cancer care and equity in society. In this report, we highlight methods in accruing to ETCTN wherein un
Autor:
Scott James Weir, Elizabeth R Kessler, Janet Baack Kukreja, Gerald Steven Falchook, Manojkumar Bupathi, Rahul Atul Parikh, Elizabeth Marie Wulff-Burchfield, Robyn Wood, Eugene K. Lee, Tammy Ham, Prasad Dandawate, Shrikant Anant, Benjamin L. Woolbright, Na Zhang, Paul Toren, Michael Dalton, Valentina Zhukova-Harrill, Jay Nicholas Umbreit, William McCulloch, John A. Taylor
Publikováno v:
Journal of Clinical Oncology. 40:e16557-e16557
e16557 Background: Fosciclopirox (F) is being developed for the treatment of non-muscle invasive (NMIBC) and muscle invasive (MIBC) bladder cancer. F is a prodrug which is rapidly and completely metabolized in blood to its active metabolite, ciclopir
Autor:
Sarmad Sadeghi, Rahul Atul Parikh, Denice D. Tsao-Wei, Susan G. Groshen, Ming Li, Leonard Joseph Appleman, Scott T. Tagawa, David M. Nanus, Ana M. Molina, Cheryl Kefauver, Moshe Chaim Ornstein, Brian I. Rini, Robert Dreicer, David I. Quinn, Primo \\'Lucky\\' N. Lara
Publikováno v:
Journal of Clinical Oncology. 40:4529-4529
4529 Background: Immune checkpoint blockade has revolutionized mRCC Tx, but primary and acquired resistance continues to result in poor patient outcomes. OX40 (CD-134) mediates IO resistance. Co-stimulatory OX40 (CD-134) activates exhausted T-cells.
Autor:
Shukun, Shen, Yiyun, Wang, Jingxuan, Dong, Rui, Zhang, Atul, Parikh, Jian-Gang, Chen, Daodao, Hu
Publikováno v:
ACS applied materialsinterfaces. 13(9)
There is a growing interest in the design and construction of artificial photosythetic materials for solar energy utilization and conversion. Inspired by the structure of thylakoid membrane, we present here a hybrid construct for light-harvesting and
Autor:
Hardik D Desai, Rupak Desai, Karan Patel, Smeet Patel, Saurav Kini, Parth P Patel, Jayesh Trivedi, Zeel Patel, Atul Parikh, Kamal Kumar Sharma
Publikováno v:
Cureus
Introduction Hyper-cytokinemia is a dreaded complication of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and an important predictor of mortality in coronavirus disease 2019 (COVID-19). The current evidence at best is still a
Autor:
Rana R. McKay, Wanling Xie, Archana Ajmera, Biren Saraiya, Mamta Parikh, Edmund Folefac, Adam C. Olson, Elisabeth I. Heath, Rahul Atul Parikh, S. Percy Ivy, Eliezer Mendel Van Allen, Neal Ian Lindeman, Geoffrey Shapiro
Publikováno v:
Journal of Clinical Oncology. 40:119-119
119 Background: Radium-223 is an α-emitting radioisotope that induces DNA double-strand breaks leading to cell death. In preclinical models, PARP inhibitors have shown efficacy as radiosensitizing agents. We designed a phase 1/2 trial to test the sa